Pitavastatin Reduces Major Atherosclerotic Cardiovascular Events in Adults with HIV.
Where this comes from
- Record sourced from PubMed, PMID 40854701.
- Also identified by DOI 10.3122/jabfm.2025.250014R0 and PMC identifier 12616793.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Initiation of pitavastatin in adults aged 40 to 75 living with HIV treated with highly active antiretroviral therapy (HAART) with low-to-moderate 10-year atherosclerotic cardiovascular disease (ASCVD) risk decreases the incidence of major cardiovascular events (MACE).
Medical subject headings
- HIV Infections
- Quinolines
- Atherosclerosis
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Cardiovascular Diseases